StonvexLoading…
StonvexStonvexStonvexCore line items from TXT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-01-04 | Annual 2018 2018-12-29 | Annual 2017 2017-12-30 | Annual 2016 2016-12-31 |
|---|---|---|---|---|
Revenue | $13.63B | $13.97B | $14.20B | $13.79B |
Operating Income | $942.00M | $1.38B | $762.00M | $876.00M |
Net Income | $815.00M | $1.22B | $307.00M | $962.00M |
EPS (Diluted) | $3.50 | $4.83 | $1.14 | $3.53 |
Total Assets | $15.02B | $14.26B | $15.34B | $15.36B |
Total Liabilities | $9.50B | $9.07B | $9.69B | $9.78B |
Cash & Equivalents | $1.36B | $1.11B | $1.26B | $1.30B |
Free Cash Flow OCF − CapEx | $675.00M | $738.00M | $513.00M | $479.00M |
Shares Outstanding | 227.96M | 235.62M | 261.47M | 270.29M |